STN1010904 clinical trials

A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehicle in Subjects with Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM Study

This study, called PHANTOM, is looking at an eye drop called STN1010904 for Fuchs Endothelial Corneal Dystrophy (FECD). It wants to see if the eye drops can improve eyesight and are safe, compared to drops with no active medicine.